{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:19:35Z","timestamp":1783106375553,"version":"3.54.6"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jceh.2024.101365","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T09:55:21Z","timestamp":1707990921000},"page":"101365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets"],"prefix":"10.1016","volume":"14","author":[{"given":"Ali","family":"Mahmoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Jalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-3917","authenticated-orcid":false,"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed H.","family":"Aghaee-Bakhtiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2024.101365_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41419-019-1672-4","article-title":"Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-\u03b21 signaling-mediated hepatocyte apoptosis","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jceh.2024.101365_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jceh.2024.101365_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5170402","article-title":"Pathogenesis of nonalcoholic steatohepatitis: interactions between liver Parenchymal and Nonparenchymal cells","volume":"2016","author":"Magee","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jceh.2024.101365_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jceh.2024.101365_bib5","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/ijms17122082","article-title":"Pathophysiology of non alcoholic fatty liver disease","volume":"17","author":"Petta","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2024.101365_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10799893.2020.1726952","article-title":"Inevitable role of TGF-\u03b21 in progression of nonalcoholic fatty liver disease","volume":"40","author":"Nair","year":"2020","journal-title":"J\u00a0Recept Signal Transduction"},{"key":"10.1016\/j.jceh.2024.101365_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2024.101365_bib8","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/nu14071331","article-title":"Investigation of the effect of curcumin on protein targets in NAFLD using bioinformatic analysis","volume":"14","author":"Mahmoudi","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2024.101365_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3654660","article-title":"Target deconvolution of fenofibrate in nonalcoholic fatty liver disease using bioinformatics analysis","volume":"2021","author":"Mahmoudi","year":"2021","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jceh.2024.101365_bib10","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.drudis.2022.05.007","article-title":"Impact of fenofibrate on NAFLD\/NASH: a genetic perspective","volume":"27","author":"Mahmoudi","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jceh.2024.101365_bib11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/jcp.30699","article-title":"The role of exosomal miRNA in nonalcoholic fatty liver disease","volume":"237","author":"Mahmoudi","year":"2022","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jceh.2024.101365_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3350\/cmh.2020.0136","article-title":"Precision medicine in nonalcoholic fatty liver disease: new therapeutic insights from genetics and systems biology","volume":"26","author":"Sookoian","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: new genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib14","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.3390\/ijms19123966","article-title":"miRNA signature in NAFLD: a turning point for a non-invasive diagnosis","volume":"19","author":"Dongiovanni","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2024.101365_bib15","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","article-title":"Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease","volume":"24","author":"Torres","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101365_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trsl.2019.07.007","article-title":"siRNA- and miRNA-based therapeutics for liver fibrosis","volume":"214","author":"Zhao","year":"2019","journal-title":"Transl Res"},{"key":"10.1016\/j.jceh.2024.101365_bib17","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/1568026618666181025113226","article-title":"Systems biology: a powerful tool for drug development","volume":"18","author":"Rai","year":"2018","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jceh.2024.101365_bib18","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/CIRCRESAHA.113.300939","article-title":"Overview of high throughput sequencing technologies to elucidate molecular pathways in cardiovascular diseases","volume":"112","author":"Churko","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jceh.2024.101365_bib19","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.3390\/nu14153244","article-title":"Therapeutic role of curcumin in diabetes: an analysis based on bioinformatic findings","volume":"14","author":"Mahmoudi","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2024.101365_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113304","article-title":"Role of statins in regulating molecular pathways following traumatic brain injury: a system pharmacology study","volume":"153","author":"Mahmoudi","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jceh.2024.101365_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression Omnibus database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jceh.2024.101365_bib22","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jceh.2024.101365_bib23","first-page":"D1031","article-title":"Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jceh.2024.101365_bib24","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jceh.2024.101365_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jceh.2024.101365_bib26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3892\/etm.2016.3069","article-title":"Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG(2) cells: an in\u00a0vitro model of non-alcoholic fatty liver disease","volume":"11","author":"Alkhatatbeh","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jceh.2024.101365_bib27","doi-asserted-by":"crossref","first-page":"D217","DOI":"10.1093\/nar\/gkac1070","article-title":"MirDIP 5.2: tissue context annotation and novel microRNA curation","volume":"51","author":"Hauschild","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jceh.2024.101365_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13148-019-0702-5","article-title":"Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome","volume":"11","author":"Sinton","year":"2019","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jceh.2024.101365_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s13040-020-00224-9","article-title":"Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease","volume":"13","author":"Hu","year":"2020","journal-title":"BioData Min"},{"key":"10.1016\/j.jceh.2024.101365_bib31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2147\/DDDT.S194787","article-title":"Salvianolic acid A attenuates CCl(4)-induced liver fibrosis by regulating the PI3K\/AKT\/mTOR, Bcl-2\/Bax and caspase-3\/cleaved caspase-3 signaling pathways","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.jceh.2024.101365_bib32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","article-title":"The role of HIF in immunity and inflammation","volume":"32","author":"McGettrick","year":"2020","journal-title":"Cell Metabol"},{"key":"10.1016\/j.jceh.2024.101365_bib33","first-page":"1","article-title":"Hypoxia and aging","volume":"51","author":"Yeo","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jceh.2024.101365_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jcmgh.2015.09.005","article-title":"Role of hypoxia-inducible factors in the development of liver fibrosis","volume":"1","author":"Roth","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32586-w","article-title":"HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver","volume":"8","author":"Arai","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2024.101365_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1165\/rcmb.2020-0492OC","article-title":"Hepatocyte HIF-1 and intermittent hypoxia independently impact liver fibrosis in murine nonalcoholic fatty liver disease","volume":"65","author":"Mesarwi","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jceh.2024.101365_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41419-020-2411-6","article-title":"TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice","volume":"11","author":"Wandrer","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jceh.2024.101365_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jceh.2024.101365_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jceh.2024.101365_bib40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12020-014-0384-x","article-title":"Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients","volume":"48","author":"Pan","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.jceh.2024.101365_bib41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jnutbio.2015.04.004","article-title":"Platelet-activating factor modulates fat storage in the liver induced by a high-refined carbohydrate-containing diet","volume":"26","author":"de Oliveira","year":"2015","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.jceh.2024.101365_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12876-019-1055-4","article-title":"Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial","volume":"19","author":"Saadati","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101365_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.2005.071118","article-title":"Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice","volume":"55","author":"Tomita","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2024.101365_bib44","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2147\/JIR.S354878","article-title":"Reduction of hepatic steatosis, oxidative stress, inflammation, ballooning and insulin resistance after therapy with safranal in NAFLD animal model: a new approach","volume":"15","author":"Sabir","year":"2022","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.jceh.2024.101365_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatology international"},{"key":"10.1016\/j.jceh.2024.101365_bib46","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.7150\/thno.44297","article-title":"Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder","volume":"10","author":"Hu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jceh.2024.101365_bib47","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/hep.29689","article-title":"New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases","volume":"67","author":"Win","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101365_bib48","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2024.101365_bib49","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1665-2681(19)30769-0","article-title":"Development of steatohepatitis in Ob\/Ob mice is dependent on Toll-like receptor 4","volume":"14","author":"Sutter","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib50","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/jcb.25453","article-title":"Dietary saturated fat promotes development of hepatic inflammation through toll-like receptor 4 in mice","volume":"117","author":"Sutter","year":"2016","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jceh.2024.101365_bib51","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101365_bib52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108917","article-title":"Stearoyl-CoA desaturase and tumorigenesis","volume":"316","author":"Kikuchi","year":"2020","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jceh.2024.101365_bib54","doi-asserted-by":"crossref","first-page":"25164","DOI":"10.1074\/jbc.M402781200","article-title":"Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and-independent mechanisms","volume":"279","author":"Miyazaki","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2024.101365_bib55","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.132384699","article-title":"Loss of stearoyl\u2013CoA desaturase-1 function protects mice against adiposity","volume":"99","author":"Ntambi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2024.101365_bib56","doi-asserted-by":"crossref","first-page":"15338","DOI":"10.1096\/fj.202000836RR","article-title":"N-glycosylation of CREBH improves lipid metabolism and attenuates lipotoxicity in NAFLD by modulating PPAR\u03b1 and SCD-1","volume":"34","author":"Zhang","year":"2020","journal-title":"Faseb J"},{"key":"10.1016\/j.jceh.2024.101365_bib57","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.18632\/aging.103082","article-title":"Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy","volume":"12","author":"Zhou","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jceh.2024.101365_bib58","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.1158042","article-title":"Regulation of hepatic lipogenesis by the transcription factor XBP1","volume":"320","author":"Lee","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jceh.2024.101365_bib59","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.tem.2017.10.003","article-title":"Insights into stearoyl-CoA desaturase-1 regulation of systemic metabolism","volume":"28","author":"ALJohani","year":"2017","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.jceh.2024.101365_bib60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4254\/wjh.v5.i10.550","article-title":"Lipotoxicity in the liver","volume":"5","author":"Z\u00e1mb\u00f3","year":"2013","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib61","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2024.101365_bib62","article-title":"Fatty acid synthase inhibitor platensimycin intervenes the development of nonalcoholic fatty liver disease in a mouse model","volume":"10","author":"Su","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jceh.2024.101365_bib63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13020-020-00378-y","article-title":"Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats","volume":"15","author":"Gao","year":"2020","journal-title":"Chin Med"},{"key":"10.1016\/j.jceh.2024.101365_bib64","doi-asserted-by":"crossref","first-page":"108753","DOI":"10.1016\/j.biopha.2019.108753","article-title":"Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE-\/- mice","volume":"113","author":"Ma","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jceh.2024.101365_bib65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jceh.2024.101365_bib66","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib67","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1440-1746.2010.06560.x","article-title":"Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis","volume":"26","author":"Zhao","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib68","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/db12-0858","article-title":"Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism","volume":"62","author":"Musso","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2024.101365_bib69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","article-title":"How cells read TGF-beta signals","volume":"1","author":"Massagu\u00e9","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jceh.2024.101365_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118619","article-title":"Significance of MR\/OPN\/HMGB1 axis in NAFLD-associated hepatic fibrogenesis","volume":"264","author":"Tang","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.jceh.2024.101365_bib71","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.3390\/ijms21155294","article-title":"VEGF-A in cardiomyocytes and heart diseases","volume":"21","author":"Braile","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2024.101365_bib72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","article-title":"VEGFA and tumour angiogenesis","volume":"273","author":"Claesson-Welsh","year":"2013","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jceh.2024.101365_bib73","first-page":"190","article-title":"Gene expression profiling reveals key genes and pathways related to the development of non-alcoholic fatty liver disease","volume":"15","author":"Wang","year":"2016","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib74","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1038\/s41401-022-00907-5","article-title":"Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells","volume":"43","author":"Shen","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jceh.2024.101365_bib75","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2018.08.032","article-title":"Amentoflavone induces apoptosis and suppresses glycolysis in glioma cells by targeting miR-124-3p","volume":"686","author":"Zhaohui","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jceh.2024.101365_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.723625","article-title":"MiR-124-3p suppresses the dysfunction of high glucose-stimulated endothelial cells by targeting G3BP2","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.jceh.2024.101365_bib78","article-title":"miR-124-3p and miR-140-3p. 2 act as negative regulators of Beclin1 and LC3 expression in the\u00a0liver of rat model with hepatic impact injury","volume":"29","author":"Niu","year":"2018","journal-title":"Biol Res"},{"key":"10.1016\/j.jceh.2024.101365_bib79","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-017-0746-0","article-title":"microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11","volume":"17","author":"Cai","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jceh.2024.101365_bib80","doi-asserted-by":"crossref","first-page":"723","DOI":"10.18821\/0869-2084-2019-64-12-723-729","article-title":"[The diagnostic importance of circulating MicroRNA for non-alcoholic fatty liver disease (review of literature)","volume":"64","author":"Gimadiev","year":"2019","journal-title":"Klin Lab Diagn"},{"key":"10.1016\/j.jceh.2024.101365_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.589994","article-title":"Repression of MicroRNA-124-3p alleviates high-fat diet\u2013induced hepatosteatosis by targeting pref-1","volume":"11","author":"Wang","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jceh.2024.101365_bib82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.isci.2018.11.028","article-title":"MicroRNA-124 regulates fatty acid and triglyceride homeostasis","volume":"10","author":"Shaw","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.jceh.2024.101365_bib83","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4093\/dmj.2016.40.5.376","article-title":"Statins increase mitochondrial and peroxisomal fatty acid oxidation in the liver and prevent non-alcoholic steatohepatitis in mice","volume":"40","author":"Park","year":"2016","journal-title":"Diabetes & metabolism journal"},{"key":"10.1016\/j.jceh.2024.101365_bib84","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00011-022-01614-x","article-title":"Increased miR-124-3p alleviates type 2 inflammatory response in allergic rhinitis via IL-4R\u03b1","volume":"71","author":"Liu","year":"2022","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jceh.2024.101365_bib85","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1096\/fj.201700673r","article-title":"Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons","volume":"32","author":"Huang","year":"2018","journal-title":"Faseb J"},{"key":"10.1016\/j.jceh.2024.101365_bib86","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00296-018-4218-7","article-title":"MicroRNA-124 inhibits TNF-\u03b1- and IL-6-induced osteoclastogenesis","volume":"39","author":"Ohnuma","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jceh.2024.101365_bib87","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12031-021-01921-8","article-title":"MiR-124 prevents the microglial proinflammatory response by inhibiting the activities of TLR4 and downstream NLRP3 in palmitic acid-treated BV2 cells","volume":"72","author":"Yang","year":"2022","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.jceh.2024.101365_bib88","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1002\/jcb.27861","article-title":"miR-124-3p attenuates neuropathic pain induced by chronic sciatic nerve injury in rats via targeting EZH2","volume":"120","author":"Zhang","year":"2019","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jceh.2024.101365_bib89","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/genes12121852","article-title":"SESN3 inhibited SMAD3 to relieve its suppression for MiR-124, thus regulating pre-adipocyte adipogenesis","volume":"12","author":"Lin","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jceh.2024.101365_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-24260-z","article-title":"In silico and in\u00a0vitro analysis of microRNAs with therapeutic potential in atherosclerosis","volume":"12","author":"Mahjoubin-Tehran","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2024.101365_bib91","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2022.03.112","article-title":"Roles of miR-124-3p\/Scd1 in urolithin A-induced brown adipocyte differentiation and succinate-dependent regulation of mitochondrial complex II","volume":"606","author":"Li","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2024.101365_bib92","doi-asserted-by":"crossref","first-page":"263","DOI":"10.17219\/acem\/131753","article-title":"miR-124-3p targeting of TGF-\u03b21 inhibits the proliferation of hypertrophic scar fibroblasts","volume":"30","author":"Zhang","year":"2021","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jceh.2024.101365_bib93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ydbio.2019.02.010","article-title":"MiR-124 regulates transforming growth factor-\u03b21 induced differentiation of lung resident mesenchymal stem cells to myofibroblast by repressing Wnt\/\u03b2-catenin signaling","volume":"449","author":"Lu","year":"2019","journal-title":"Dev Biol"},{"key":"10.1016\/j.jceh.2024.101365_bib94","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvu184","article-title":"The microRNA-15 family inhibits the TGF\u03b2-pathway in the heart","volume":"104","author":"Tijsen","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jceh.2024.101365_bib95","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12935-022-02754-0","article-title":"A\u00a0review on the role of mir-16-5p in the carcinogenesis","volume":"22","author":"Ghafouri-Fard","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jceh.2024.101365_bib96","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtn.2016.11.005","article-title":"Reverse expression of aging-associated molecules through transfection of miRNAs to aged mice","volume":"6","author":"Kim","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jceh.2024.101365_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28854-4","article-title":"Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers","volume":"8","author":"L\u00f3pez-Riera","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2024.101365_bib98","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.3748\/wjg.v25.i42.6322","article-title":"MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes","volume":"25","author":"Elemeery","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101365_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.736677","article-title":"Analysis of miRNAs profiles in serum of patients with steatosis and steatohepatitis","volume":"9","author":"Vulf","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jceh.2024.101365_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2024.101365_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144191","article-title":"MicroRNA 16-5p is upregulated in calorie-restricted mice and modulates inflammatory cytokines of macrophages","volume":"725","author":"Yamada","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.jceh.2024.101365_bib102","doi-asserted-by":"crossref","first-page":"78566","DOI":"10.18632\/oncotarget.12479","article-title":"Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jceh.2024.101365_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102461","article-title":"MicroRNA-16 inhibits the TLR4\/NF-\u03baB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea","volume":"298","author":"Xi","year":"2022","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2024.101365_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108664","article-title":"miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury","volume":"112","author":"Yang","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jceh.2024.101365_bib105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biopha.2018.05.041","article-title":"miR-15a\/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-\u03b2 signaling pathway","volume":"104","author":"Jin","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jceh.2024.101365_bib106","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","article-title":"miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis","volume":"50","author":"Guo","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101365_bib107","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3892\/ijmm.2016.2497","article-title":"MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4","volume":"37","author":"Liang","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jceh.2024.101365_bib108","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biochi.2015.10.004","article-title":"MicroRNA-16 modulates macrophage polarization leading to improved insulin sensitivity in myoblasts","volume":"119","author":"Talari","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.jceh.2024.101365_bib109","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jceh.2024.101365_bib110","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/jgh.12268","article-title":"Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease","volume":"28","author":"Sharma","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T13:04:48Z","timestamp":1731330288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688324000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0973688324000227"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101365","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101365"}}